藥 物 回 收
|
| |
| Canada: Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug (English only) |
| |
Health Canada announces that Marcan Pharmaceuticals Inc. is recalling 2 lots of MAR-Amlodipine 5 mg tablets (lot number: 2472021, 2472021A) because some bottles may contain the wrong tablets, which they have identified as midodrine 2.5 mg tablets.
MAR-Amlodipine is used to treat high blood pressure and chest pain in adults and children 6 years of age and older. The tablets are white to off-white, flat and eight-sided, with a line across the middle. One side has “210” and “5” printed on it, and the other side is blank.
Midodrine 2.5 mg tablets are white, round, and marked with ‘M2’ on one side and have a line across the middle on the other side. Midodrine is used to treat low blood pressure and substituting amlodipine (5 mg) with midodrine (2.5 mg) can lead to serious side effects such as a dangerous increase in blood pressure, dizziness, fainting and organ damage.
Patients with other conditions (e.g., pheochromocytoma, glaucoma, or hyperthyroidism) and those taking other medications could experience different side effects with varying levels of severity if they take the midodrine by mistake. Some patients may not experience any symptoms if their blood pressure is elevated, and may only know by measuring their blood pressure. Elevated blood pressure without symptoms can still result in significant harm to a patient. Children taking the wrong medication may face a higher risk of serious side effects and potential harm.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/two-lots-mar-amlodipine-5-mg-tablets-recalled-some-bottles-may-contain-wrong-drug
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Monday, Feb 9, 2025
Issued at HKT 14:45
|
| |
